Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
Pliant Therapeutics, Inc.: Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer
Dr. Imbert brings 25 years of strategic clinical to commercial-stage manufacturing and drug development experience SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, ...
Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping
Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.
manilatimes4d
Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer
Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of ...
AI can call the shots on drug making because it 'doesn't have a career at stake,' major pharma CEO says
AI can call the shots on drug making because it 'doesn't have a career at stake,' major pharma CEO says Sanofi's CEO said the ...